Cargando…
Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial
BACKGROUND: Although among women a decreasing prevalence of human papillomavirus (HPV) infection with increasing age has been consistently observed in high-resource countries, different age profiles have been reported elsewhere. METHODS: We compared the age profile of high-risk (HR)-HPV prevalence i...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669053/ https://www.ncbi.nlm.nih.gov/pubmed/23706168 http://dx.doi.org/10.1186/1471-2334-13-238 |
_version_ | 1782271692973801472 |
---|---|
author | Baussano, Iacopo Franceschi, Silvia Gillio-Tos, Anna Carozzi, Francesca Confortini, Massimo Palma, Paolo Dalla De Lillo, Margherita Del Mistro, Annarosa De Marco, Laura Naldoni, Carlo Pierotti, Paola Schincaglia, Patrizia Segnan, Nereo Zorzi, Manuel Giorgi-Rossi, Paolo Ronco, Guglielmo |
author_facet | Baussano, Iacopo Franceschi, Silvia Gillio-Tos, Anna Carozzi, Francesca Confortini, Massimo Palma, Paolo Dalla De Lillo, Margherita Del Mistro, Annarosa De Marco, Laura Naldoni, Carlo Pierotti, Paola Schincaglia, Patrizia Segnan, Nereo Zorzi, Manuel Giorgi-Rossi, Paolo Ronco, Guglielmo |
author_sort | Baussano, Iacopo |
collection | PubMed |
description | BACKGROUND: Although among women a decreasing prevalence of human papillomavirus (HPV) infection with increasing age has been consistently observed in high-resource countries, different age profiles have been reported elsewhere. METHODS: We compared the age profile of high-risk (HR)-HPV prevalence in nine different areas of Northern and Central Italy by studying the women recruited in the intervention arm of the New Technologies in Cervical Cancer study and tested by Hybrid Capture 2. Differences in the age-distribution of HPV infection were investigated in each centre by the joinpoint approach in a logistic model. 46,900 women aged 25 to 60 years were included in the analysis. RESULTS: The HR-HPV age-standardised (on Italian population) prevalence ranged from 5.7% (Trento) to 10.3% (Ravenna). HR-HPV prevalence decreased as a logistic function of increasing age in 6 of 9 centres (Trento, Verona, Florence, Bologna, Imola, and Viterbo). The effect of age on HR-HPV prevalence slopes did not differ significantly among these 6 centres, whereas significant heterogeneity in intercepts (p < 0.001) was found, reflecting different overall HR-HPV prevalence between centres. One significant joinpoint was observed in 2 centres (Padua and Ravenna), indicating that the decrease in HR-HPV prevalence by age was better described using a function composed with two logistic segments. In Padua HR-HPV prevalence decreased only slightly up to 39 years but showed a steep downturn thereafter. In Ravenna HR-HPV prevalence decreased steeply down to 45 years of age and then showed a plateau. Finally, in Turin two significant joinpoints were observed: prevalence decreased only after age 29 and showed a plateau after age 39. CONCLUSIONS: Our results showed substantial differences in overall and age-specific HR-HPV prevalence across Italian areas. These findings may be related to different timing of changes in sexual behaviours across regions. Age-specific HR-HPV prevalence in Italy does not support an influence of age per se. |
format | Online Article Text |
id | pubmed-3669053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36690532013-06-01 Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial Baussano, Iacopo Franceschi, Silvia Gillio-Tos, Anna Carozzi, Francesca Confortini, Massimo Palma, Paolo Dalla De Lillo, Margherita Del Mistro, Annarosa De Marco, Laura Naldoni, Carlo Pierotti, Paola Schincaglia, Patrizia Segnan, Nereo Zorzi, Manuel Giorgi-Rossi, Paolo Ronco, Guglielmo BMC Infect Dis Research Article BACKGROUND: Although among women a decreasing prevalence of human papillomavirus (HPV) infection with increasing age has been consistently observed in high-resource countries, different age profiles have been reported elsewhere. METHODS: We compared the age profile of high-risk (HR)-HPV prevalence in nine different areas of Northern and Central Italy by studying the women recruited in the intervention arm of the New Technologies in Cervical Cancer study and tested by Hybrid Capture 2. Differences in the age-distribution of HPV infection were investigated in each centre by the joinpoint approach in a logistic model. 46,900 women aged 25 to 60 years were included in the analysis. RESULTS: The HR-HPV age-standardised (on Italian population) prevalence ranged from 5.7% (Trento) to 10.3% (Ravenna). HR-HPV prevalence decreased as a logistic function of increasing age in 6 of 9 centres (Trento, Verona, Florence, Bologna, Imola, and Viterbo). The effect of age on HR-HPV prevalence slopes did not differ significantly among these 6 centres, whereas significant heterogeneity in intercepts (p < 0.001) was found, reflecting different overall HR-HPV prevalence between centres. One significant joinpoint was observed in 2 centres (Padua and Ravenna), indicating that the decrease in HR-HPV prevalence by age was better described using a function composed with two logistic segments. In Padua HR-HPV prevalence decreased only slightly up to 39 years but showed a steep downturn thereafter. In Ravenna HR-HPV prevalence decreased steeply down to 45 years of age and then showed a plateau. Finally, in Turin two significant joinpoints were observed: prevalence decreased only after age 29 and showed a plateau after age 39. CONCLUSIONS: Our results showed substantial differences in overall and age-specific HR-HPV prevalence across Italian areas. These findings may be related to different timing of changes in sexual behaviours across regions. Age-specific HR-HPV prevalence in Italy does not support an influence of age per se. BioMed Central 2013-05-24 /pmc/articles/PMC3669053/ /pubmed/23706168 http://dx.doi.org/10.1186/1471-2334-13-238 Text en Copyright © 2013 Baussano et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Baussano, Iacopo Franceschi, Silvia Gillio-Tos, Anna Carozzi, Francesca Confortini, Massimo Palma, Paolo Dalla De Lillo, Margherita Del Mistro, Annarosa De Marco, Laura Naldoni, Carlo Pierotti, Paola Schincaglia, Patrizia Segnan, Nereo Zorzi, Manuel Giorgi-Rossi, Paolo Ronco, Guglielmo Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial |
title | Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial |
title_full | Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial |
title_fullStr | Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial |
title_full_unstemmed | Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial |
title_short | Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial |
title_sort | difference in overall and age-specific prevalence of high-risk human papillomavirus infection in italy: evidence from ntcc trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669053/ https://www.ncbi.nlm.nih.gov/pubmed/23706168 http://dx.doi.org/10.1186/1471-2334-13-238 |
work_keys_str_mv | AT baussanoiacopo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT franceschisilvia differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT gilliotosanna differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT carozzifrancesca differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT confortinimassimo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT palmapaolodalla differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT delillomargherita differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT delmistroannarosa differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT demarcolaura differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT naldonicarlo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT pierottipaola differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT schincagliapatrizia differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT segnannereo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT zorzimanuel differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT giorgirossipaolo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial AT roncoguglielmo differenceinoverallandagespecificprevalenceofhighriskhumanpapillomavirusinfectioninitalyevidencefromntcctrial |